T-cells
- All
- News
- Videos
-
Indian-Made Gene Therapy For Blood Cancer Shows 73% Response Rate In Clinical Trials
An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in India, according to results of clinical trials published in The Lancet Haematology journal.
-
Breakthrough New Therapy Makes Deadly Brain Tumour Disappear In Days
Under CAR-T, a patient's own T-cells are collected and re-engineered to identify surface markers on the outside of cancer cells before being injected in the body again.
-
Common Colds Can Provide Protection Against Covid: UK Study
High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.
-
T-Cells - The Unsung Heroes In The Fight Against Omicron
An unsung arm of the immune system appears to protect against severe disease with the omicron variant even when antibodies wane, helping to explain why a record wave of infections hasn't engulfed hospitals so far.
-
UK Researchers Identify T-Cell Targets For Future Covid Vaccines
British researchers said today they had identified proteins in the coronavirus that are recognised by T-cells of people who are exposed to the virus but resist infection, possibly providing a new target for vaccine developers.
-
Tata Memorial Hospital, IIT Bombay Collaborate for ‘First in India’ CAR-T Cell Therapy for Cancer Treatment
Tata Memorial Hospital and IIT Bombay collaborated for the first Chimeric Antigen Receptor T-cell (CAR-T) therapy, a type of gene therapy for blood cancer treatment, in India, which was conducted on Friday, June 4 in Mumbai.
-
Covaxin Vaccine Shows Long-Term Antibody Response, Says Bharat Biotech
Covaxin, a COVID-19 vaccine being developed by Bharat Biotech, showed long-term antibody and T-cell (immune) memory responses three months after the shot in phase 1 volunteers and tolerable safety outcomes in Phase 2 study, the city-based company has said, suggesting the antibodies may persist for six to 12 months.
-
Study Decodes Immune System's Requirements For Protection Against COVID-19
Scientists have assessed the novel coronavirus infection in monkeys and found that the immune system's T-Cells may contribute to protection against the virus if antibody responses are suboptimal, an advance which may aid in the development of vaccines and therapeutics for COVID-19.
-
In Coronavirus, Antibodies May Wane, T-Cells Are The New Hero
Antibodies have become a familiar word in the pandemic era, perhaps suggesting they're the best hope for keeping the deadly coronavirus at bay. But when crucial vaccine data was released this week, the spotlight panned to an unsung immune player: T cells.
-
How Experimental Supercells Cured An Infant's Deadly Genetic Illness
When a person's immune system is impaired by a genetic disease, a bone-marrow transplant can be a powerful therapeutic tool, but with a major downside: during the first few months the recipient's defenses against viruses are severely weakened. The slightest infection can lead to a hospital trip.
-
New Spray Gel To Help Ward Off Cancer Recurrence Post-Surgery
The spray gel, tested on mice, was not only successful in inhibiting the recurrence of tumours from the area on the body, but also controlled the development of tumours in other parts of the body.
-
U.S. Scientists Discover Potential Treatment For Blood Cancer
Scientists in Stanford University have found out a different molecule CD22, which can be targetted against genetically modified T-cells in CAR T-cell therapy - as an effective treatment for leukaemia.
-
Indian-American Scientist Engineers T-Cells To Treat Pancreatic Cancer
In ground-breaking research, an Indian-American scientist has engineered T-cells -- a type of immune cells -- to break the pancreatic cancer's physical and immunological walls using immunotherapy.
-
Modified T-cell trick wipes out US child's leukaemia
US researchers on Monday reported encouraging success with a new type of immune cell therapy that wiped out leukaemia in a young girl by using her modified T cells to fight the cancer.
-
Indian-Made Gene Therapy For Blood Cancer Shows 73% Response Rate In Clinical Trials
An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in India, according to results of clinical trials published in The Lancet Haematology journal.
-
Breakthrough New Therapy Makes Deadly Brain Tumour Disappear In Days
Under CAR-T, a patient's own T-cells are collected and re-engineered to identify surface markers on the outside of cancer cells before being injected in the body again.
-
Common Colds Can Provide Protection Against Covid: UK Study
High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.
-
T-Cells - The Unsung Heroes In The Fight Against Omicron
An unsung arm of the immune system appears to protect against severe disease with the omicron variant even when antibodies wane, helping to explain why a record wave of infections hasn't engulfed hospitals so far.
-
UK Researchers Identify T-Cell Targets For Future Covid Vaccines
British researchers said today they had identified proteins in the coronavirus that are recognised by T-cells of people who are exposed to the virus but resist infection, possibly providing a new target for vaccine developers.
-
Tata Memorial Hospital, IIT Bombay Collaborate for ‘First in India’ CAR-T Cell Therapy for Cancer Treatment
Tata Memorial Hospital and IIT Bombay collaborated for the first Chimeric Antigen Receptor T-cell (CAR-T) therapy, a type of gene therapy for blood cancer treatment, in India, which was conducted on Friday, June 4 in Mumbai.
-
Covaxin Vaccine Shows Long-Term Antibody Response, Says Bharat Biotech
Covaxin, a COVID-19 vaccine being developed by Bharat Biotech, showed long-term antibody and T-cell (immune) memory responses three months after the shot in phase 1 volunteers and tolerable safety outcomes in Phase 2 study, the city-based company has said, suggesting the antibodies may persist for six to 12 months.
-
Study Decodes Immune System's Requirements For Protection Against COVID-19
Scientists have assessed the novel coronavirus infection in monkeys and found that the immune system's T-Cells may contribute to protection against the virus if antibody responses are suboptimal, an advance which may aid in the development of vaccines and therapeutics for COVID-19.
-
In Coronavirus, Antibodies May Wane, T-Cells Are The New Hero
Antibodies have become a familiar word in the pandemic era, perhaps suggesting they're the best hope for keeping the deadly coronavirus at bay. But when crucial vaccine data was released this week, the spotlight panned to an unsung immune player: T cells.
-
How Experimental Supercells Cured An Infant's Deadly Genetic Illness
When a person's immune system is impaired by a genetic disease, a bone-marrow transplant can be a powerful therapeutic tool, but with a major downside: during the first few months the recipient's defenses against viruses are severely weakened. The slightest infection can lead to a hospital trip.
-
New Spray Gel To Help Ward Off Cancer Recurrence Post-Surgery
The spray gel, tested on mice, was not only successful in inhibiting the recurrence of tumours from the area on the body, but also controlled the development of tumours in other parts of the body.
-
U.S. Scientists Discover Potential Treatment For Blood Cancer
Scientists in Stanford University have found out a different molecule CD22, which can be targetted against genetically modified T-cells in CAR T-cell therapy - as an effective treatment for leukaemia.
-
Indian-American Scientist Engineers T-Cells To Treat Pancreatic Cancer
In ground-breaking research, an Indian-American scientist has engineered T-cells -- a type of immune cells -- to break the pancreatic cancer's physical and immunological walls using immunotherapy.
-
Modified T-cell trick wipes out US child's leukaemia
US researchers on Monday reported encouraging success with a new type of immune cell therapy that wiped out leukaemia in a young girl by using her modified T cells to fight the cancer.
